

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of interleukin-17 production (GO:0032740) | 5.65672587 |
| 2 | DNA deamination (GO:0045006) | 5.31010620 |
| 3 | negative regulation of B cell apoptotic process (GO:0002903) | 5.19519173 |
| 4 | response to interferon-beta (GO:0035456) | 5.14909612 |
| 5 | regulation of memory T cell differentiation (GO:0043380) | 4.72326701 |
| 6 | rRNA catabolic process (GO:0016075) | 4.59721099 |
| 7 | regulation of regulatory T cell differentiation (GO:0045589) | 4.50365262 |
| 8 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 4.46008119 |
| 9 | positive regulation of defense response to virus by host (GO:0002230) | 4.38573279 |
| 10 | fucose catabolic process (GO:0019317) | 4.35468879 |
| 11 | L-fucose metabolic process (GO:0042354) | 4.35468879 |
| 12 | L-fucose catabolic process (GO:0042355) | 4.35468879 |
| 13 | multicellular organism reproduction (GO:0032504) | 4.30032392 |
| 14 | positive regulation of antigen processing and presentation (GO:0002579) | 4.16801161 |
| 15 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 4.12512317 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.02756649 |
| 17 | negative regulation of cell killing (GO:0031342) | 4.02756649 |
| 18 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.99691814 |
| 19 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.89849666 |
| 20 | negative regulation of mast cell activation (GO:0033004) | 3.88741897 |
| 21 | behavioral response to nicotine (GO:0035095) | 3.85182237 |
| 22 | regulation of germinal center formation (GO:0002634) | 3.79303468 |
| 23 | platelet dense granule organization (GO:0060155) | 3.66265491 |
| 24 | protein-cofactor linkage (GO:0018065) | 3.61754539 |
| 25 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.61358473 |
| 26 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.55735268 |
| 27 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.50742367 |
| 28 | negative thymic T cell selection (GO:0045060) | 3.49285535 |
| 29 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.49209009 |
| 30 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.48607547 |
| 31 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.45504438 |
| 32 | cellular response to exogenous dsRNA (GO:0071360) | 3.44947011 |
| 33 | negative T cell selection (GO:0043383) | 3.42289861 |
| 34 | regulation of defense response to virus by host (GO:0050691) | 3.41062840 |
| 35 | regulation of interleukin-17 production (GO:0032660) | 3.41016553 |
| 36 | regulation of B cell apoptotic process (GO:0002902) | 3.40355634 |
| 37 | mannosylation (GO:0097502) | 3.40210067 |
| 38 | cellular response to interleukin-15 (GO:0071350) | 3.40118891 |
| 39 | positive thymic T cell selection (GO:0045059) | 3.38321746 |
| 40 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.36257850 |
| 41 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.35435366 |
| 42 | response to gravity (GO:0009629) | 3.34817874 |
| 43 | regulation of immunoglobulin secretion (GO:0051023) | 3.30257390 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.21779664 |
| 45 | response to interferon-alpha (GO:0035455) | 3.21702011 |
| 46 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.18493184 |
| 47 | mast cell activation (GO:0045576) | 3.17631805 |
| 48 | regulation of antigen processing and presentation (GO:0002577) | 3.16304557 |
| 49 | mast cell activation involved in immune response (GO:0002279) | 3.14256952 |
| 50 | mast cell degranulation (GO:0043303) | 3.14256952 |
| 51 | T-helper cell differentiation (GO:0042093) | 3.13412279 |
| 52 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.13412279 |
| 53 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.10855990 |
| 54 | S-adenosylmethionine metabolic process (GO:0046500) | 3.08679655 |
| 55 | regulation of activation of Janus kinase activity (GO:0010533) | 3.08674611 |
| 56 | sleep (GO:0030431) | 3.07720386 |
| 57 | positive regulation of activated T cell proliferation (GO:0042104) | 3.04470802 |
| 58 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.02283296 |
| 59 | cytidine catabolic process (GO:0006216) | 2.98121405 |
| 60 | cytidine deamination (GO:0009972) | 2.98121405 |
| 61 | cytidine metabolic process (GO:0046087) | 2.98121405 |
| 62 | glutathione biosynthetic process (GO:0006750) | 2.97242189 |
| 63 | rhodopsin mediated signaling pathway (GO:0016056) | 2.95213560 |
| 64 | regulation of T-helper 1 type immune response (GO:0002825) | 2.93172839 |
| 65 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.89303716 |
| 66 | natural killer cell activation (GO:0030101) | 2.89116013 |
| 67 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.86360212 |
| 68 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.86360212 |
| 69 | positive regulation of T cell mediated immunity (GO:0002711) | 2.85182588 |
| 70 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.81610025 |
| 71 | T cell differentiation involved in immune response (GO:0002292) | 2.81118011 |
| 72 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.81118011 |
| 73 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.81118011 |
| 74 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.79831305 |
| 75 | response to interleukin-15 (GO:0070672) | 2.78500238 |
| 76 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.77106947 |
| 77 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.76349719 |
| 78 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.75992238 |
| 79 | reproduction (GO:0000003) | 2.72859559 |
| 80 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.70617333 |
| 81 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.70552023 |
| 82 | positive regulation of adaptive immune response (GO:0002821) | 2.68198823 |
| 83 | positive regulation of DNA recombination (GO:0045911) | 2.67810643 |
| 84 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.66499423 |
| 85 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.65545337 |
| 86 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.65099103 |
| 87 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.61988801 |
| 88 | positive regulation of interferon-gamma production (GO:0032729) | 2.61164693 |
| 89 | endoderm formation (GO:0001706) | 2.60584167 |
| 90 | negative regulation of viral genome replication (GO:0045071) | 2.59115222 |
| 91 | interferon-gamma production (GO:0032609) | 2.56049312 |
| 92 | positive regulation of isotype switching (GO:0045830) | 2.55488051 |
| 93 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.55345689 |
| 94 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.53584969 |
| 95 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.52558291 |
| 96 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.49135631 |
| 97 | isotype switching (GO:0045190) | 2.49135631 |
| 98 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.49135631 |
| 99 | thymic T cell selection (GO:0045061) | 2.48830435 |
| 100 | cellular response to interferon-beta (GO:0035458) | 2.48234808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.41399500 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.81691565 |
| 3 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.87016882 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.77050880 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.61767450 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.49826781 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.20199406 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.97881330 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.81851956 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.81622781 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.72408971 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.54680521 |
| 13 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.39515242 |
| 14 | GATA3_26560356_Chip-Seq_TH2_Human | 2.33278522 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.32119883 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.23600093 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.12152721 |
| 18 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.05921173 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 1.99488362 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.99289792 |
| 21 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.94279483 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.92812629 |
| 23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.91704399 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.89531681 |
| 25 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.85051540 |
| 26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.83725413 |
| 27 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.82059382 |
| 28 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.78831184 |
| 29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78204447 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72802938 |
| 31 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.67124312 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66933636 |
| 33 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.59574175 |
| 34 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.55359160 |
| 35 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.55170118 |
| 36 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.51719724 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51718720 |
| 38 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.49376580 |
| 39 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.48224956 |
| 40 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.43798838 |
| 41 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.43719053 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42233941 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.39070654 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37767977 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36662412 |
| 46 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.35909492 |
| 47 | AR_20517297_ChIP-Seq_VCAP_Human | 1.34857342 |
| 48 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.33649739 |
| 49 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33221336 |
| 50 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.32511725 |
| 51 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.32379747 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28142424 |
| 53 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.27190834 |
| 54 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.26284117 |
| 55 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.25596276 |
| 56 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22564524 |
| 57 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21672533 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20124367 |
| 59 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.19607934 |
| 60 | ERA_21632823_ChIP-Seq_H3396_Human | 1.17226046 |
| 61 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15851337 |
| 62 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15039724 |
| 63 | VDR_22108803_ChIP-Seq_LS180_Human | 1.12743541 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11467476 |
| 65 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.11299236 |
| 66 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.09175445 |
| 67 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.06930369 |
| 68 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.06688183 |
| 69 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.06688183 |
| 70 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.05144090 |
| 71 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.03756741 |
| 72 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.03676279 |
| 73 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.03676279 |
| 74 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02973643 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02797619 |
| 76 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.02459211 |
| 77 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.02345725 |
| 78 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.01194024 |
| 79 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00776258 |
| 80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00447023 |
| 81 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.99184013 |
| 82 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96829801 |
| 83 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96599429 |
| 84 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95545687 |
| 85 | NCOR_22424771_ChIP-Seq_293T_Human | 0.95430971 |
| 86 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.94315746 |
| 87 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92600833 |
| 88 | MAF_26560356_Chip-Seq_TH1_Human | 0.92097048 |
| 89 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.92082605 |
| 90 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92077340 |
| 91 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.91194614 |
| 92 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.90616554 |
| 93 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89427786 |
| 94 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88975875 |
| 95 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.87755505 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87148783 |
| 97 | P300_27268052_Chip-Seq_Bcells_Human | 0.87002902 |
| 98 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.86988413 |
| 99 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86940063 |
| 100 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86826621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.23344933 |
| 2 | MP0003011_delayed_dark_adaptation | 4.13938366 |
| 3 | MP0005671_abnormal_response_to | 3.56114571 |
| 4 | MP0000465_gastrointestinal_hemorrhage | 3.52480909 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 3.49840302 |
| 6 | MP0002166_altered_tumor_susceptibility | 3.37534053 |
| 7 | MP0003724_increased_susceptibility_to | 2.93478402 |
| 8 | MP0002006_tumorigenesis | 2.68713495 |
| 9 | MP0006054_spinal_hemorrhage | 2.68374262 |
| 10 | MP0000372_irregular_coat_pigmentation | 2.66029651 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.46536152 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.42403798 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.35967920 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.29209986 |
| 15 | MP0003195_calcinosis | 2.27442033 |
| 16 | MP0005075_abnormal_melanosome_morpholog | 2.13430754 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.09873413 |
| 18 | MP0003436_decreased_susceptibility_to | 2.03366529 |
| 19 | MP0001800_abnormal_humoral_immune | 2.01592655 |
| 20 | MP0002723_abnormal_immune_serum | 1.97679585 |
| 21 | MP0002009_preneoplasia | 1.90052280 |
| 22 | MP0009785_altered_susceptibility_to | 1.90017426 |
| 23 | MP0001790_abnormal_immune_system | 1.89706269 |
| 24 | MP0005387_immune_system_phenotype | 1.89706269 |
| 25 | MP0008872_abnormal_physiological_respon | 1.88273983 |
| 26 | MP0001819_abnormal_immune_cell | 1.84831321 |
| 27 | MP0002420_abnormal_adaptive_immunity | 1.84009537 |
| 28 | MP0005253_abnormal_eye_physiology | 1.73049825 |
| 29 | MP0000685_abnormal_immune_system | 1.71874495 |
| 30 | MP0002452_abnormal_antigen_presenting | 1.67735362 |
| 31 | MP0005025_abnormal_response_to | 1.67491240 |
| 32 | MP0004043_abnormal_pH_regulation | 1.66236411 |
| 33 | MP0010368_abnormal_lymphatic_system | 1.60647889 |
| 34 | MP0000013_abnormal_adipose_tissue | 1.58838155 |
| 35 | MP0002933_joint_inflammation | 1.57863546 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.57808329 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.55771314 |
| 38 | MP0001764_abnormal_homeostasis | 1.54254458 |
| 39 | MP0001986_abnormal_taste_sensitivity | 1.51818965 |
| 40 | MP0006072_abnormal_retinal_apoptosis | 1.51597434 |
| 41 | MP0002398_abnormal_bone_marrow | 1.49949634 |
| 42 | MP0002405_respiratory_system_inflammati | 1.48610917 |
| 43 | MP0001853_heart_inflammation | 1.43057457 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.41604471 |
| 45 | MP0009764_decreased_sensitivity_to | 1.39150644 |
| 46 | MP0005167_abnormal_blood-brain_barrier | 1.38353762 |
| 47 | MP0000716_abnormal_immune_system | 1.36834739 |
| 48 | MP0002419_abnormal_innate_immunity | 1.35659454 |
| 49 | MP0003786_premature_aging | 1.31965898 |
| 50 | MP0001845_abnormal_inflammatory_respons | 1.31549736 |
| 51 | MP0001348_abnormal_lacrimal_gland | 1.27214751 |
| 52 | MP0002722_abnormal_immune_system | 1.27048638 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.25130854 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.24055110 |
| 55 | MP0001879_abnormal_lymphatic_vessel | 1.21828261 |
| 56 | MP0008875_abnormal_xenobiotic_pharmacok | 1.17696523 |
| 57 | MP0002102_abnormal_ear_morphology | 1.17119030 |
| 58 | MP0002429_abnormal_blood_cell | 1.15440458 |
| 59 | MP0003252_abnormal_bile_duct | 1.13958652 |
| 60 | MP0001958_emphysema | 1.12123847 |
| 61 | MP0005464_abnormal_platelet_physiology | 1.07738988 |
| 62 | MP0001919_abnormal_reproductive_system | 1.04373078 |
| 63 | MP0000703_abnormal_thymus_morphology | 1.03924286 |
| 64 | MP0002876_abnormal_thyroid_physiology | 1.03023660 |
| 65 | MP0003866_abnormal_defecation | 1.01068396 |
| 66 | MP0003303_peritoneal_inflammation | 0.96866722 |
| 67 | MP0005332_abnormal_amino_acid | 0.95593496 |
| 68 | MP0005551_abnormal_eye_electrophysiolog | 0.91720202 |
| 69 | MP0005645_abnormal_hypothalamus_physiol | 0.91095440 |
| 70 | MP0006036_abnormal_mitochondrial_physio | 0.86957961 |
| 71 | MP0005174_abnormal_tail_pigmentation | 0.85858340 |
| 72 | MP0008995_early_reproductive_senescence | 0.82847215 |
| 73 | MP0002396_abnormal_hematopoietic_system | 0.82061963 |
| 74 | MP0003186_abnormal_redox_activity | 0.81532394 |
| 75 | MP0008469_abnormal_protein_level | 0.81326028 |
| 76 | MP0005390_skeleton_phenotype | 0.80769391 |
| 77 | MP0010329_abnormal_lipoprotein_level | 0.74727112 |
| 78 | MP0005083_abnormal_biliary_tract | 0.73039256 |
| 79 | MP0005377_hearing/vestibular/ear_phenot | 0.71767311 |
| 80 | MP0003878_abnormal_ear_physiology | 0.71767311 |
| 81 | MP0008775_abnormal_heart_ventricle | 0.71218327 |
| 82 | MP0001968_abnormal_touch/_nociception | 0.67358099 |
| 83 | MP0005310_abnormal_salivary_gland | 0.66773738 |
| 84 | MP0004885_abnormal_endolymph | 0.65937280 |
| 85 | MP0005389_reproductive_system_phenotype | 0.65236500 |
| 86 | MP0001501_abnormal_sleep_pattern | 0.65051549 |
| 87 | MP0003638_abnormal_response/metabolism_ | 0.64788189 |
| 88 | MP0001905_abnormal_dopamine_level | 0.63626272 |
| 89 | MP0001663_abnormal_digestive_system | 0.63587989 |
| 90 | MP0001765_abnormal_ion_homeostasis | 0.63139698 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 0.62557295 |
| 92 | MP0008877_abnormal_DNA_methylation | 0.61333817 |
| 93 | MP0001873_stomach_inflammation | 0.60859902 |
| 94 | MP0000604_amyloidosis | 0.60349866 |
| 95 | MP0000613_abnormal_salivary_gland | 0.58018222 |
| 96 | MP0000538_abnormal_urinary_bladder | 0.57133281 |
| 97 | MP0003300_gastrointestinal_ulcer | 0.57057605 |
| 98 | MP0003646_muscle_fatigue | 0.55636359 |
| 99 | MP0005165_increased_susceptibility_to | 0.54703597 |
| 100 | MP0003448_altered_tumor_morphology | 0.54478958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prostate neoplasm (HP:0100787) | 4.54764921 |
| 2 | IgG deficiency (HP:0004315) | 4.19637706 |
| 3 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.83273664 |
| 4 | Severe combined immunodeficiency (HP:0004430) | 3.76281192 |
| 5 | Myositis (HP:0100614) | 3.59324447 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.45698465 |
| 7 | Hypokalemic alkalosis (HP:0001949) | 3.40737461 |
| 8 | Metabolic alkalosis (HP:0200114) | 3.35748423 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 3.35460821 |
| 10 | Optic neuritis (HP:0100653) | 3.35460821 |
| 11 | Abnormality of T cell physiology (HP:0011840) | 3.32807503 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.22789361 |
| 13 | Bile duct proliferation (HP:0001408) | 3.18770069 |
| 14 | Abnormal biliary tract physiology (HP:0012439) | 3.18770069 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 3.18652984 |
| 16 | Abnormality of T cells (HP:0002843) | 3.17463251 |
| 17 | Abnormality of T cell number (HP:0011839) | 3.16941449 |
| 18 | Stomach cancer (HP:0012126) | 3.16338452 |
| 19 | 3-Methylglutaconic aciduria (HP:0003535) | 3.13902990 |
| 20 | T lymphocytopenia (HP:0005403) | 3.13183383 |
| 21 | Abolished electroretinogram (ERG) (HP:0000550) | 3.10837297 |
| 22 | Abnormality of the prostate (HP:0008775) | 3.08572728 |
| 23 | Type I transferrin isoform profile (HP:0003642) | 3.05141828 |
| 24 | Retinal dysplasia (HP:0007973) | 3.05019586 |
| 25 | Orchitis (HP:0100796) | 3.00096243 |
| 26 | Alkalosis (HP:0001948) | 2.98170026 |
| 27 | Combined immunodeficiency (HP:0005387) | 2.90941409 |
| 28 | Thyroiditis (HP:0100646) | 2.82660947 |
| 29 | Pustule (HP:0200039) | 2.79519169 |
| 30 | Abnormality of the renal cortex (HP:0011035) | 2.76640777 |
| 31 | Abnormality of midbrain morphology (HP:0002418) | 2.75508611 |
| 32 | Molar tooth sign on MRI (HP:0002419) | 2.75508611 |
| 33 | Dry hair (HP:0011359) | 2.72401618 |
| 34 | Congenital stationary night blindness (HP:0007642) | 2.66055899 |
| 35 | Pulmonary fibrosis (HP:0002206) | 2.62922713 |
| 36 | Hypoproteinemia (HP:0003075) | 2.60221774 |
| 37 | Congenital, generalized hypertrichosis (HP:0004540) | 2.55741598 |
| 38 | Anhidrosis (HP:0000970) | 2.51295648 |
| 39 | Encephalitis (HP:0002383) | 2.49782762 |
| 40 | Stomatitis (HP:0010280) | 2.46742166 |
| 41 | Delayed CNS myelination (HP:0002188) | 2.38398622 |
| 42 | Type 2 muscle fiber atrophy (HP:0003554) | 2.37393729 |
| 43 | Renal cortical cysts (HP:0000803) | 2.35963792 |
| 44 | Renal duplication (HP:0000075) | 2.35012150 |
| 45 | Hypomagnesemia (HP:0002917) | 2.31584158 |
| 46 | Abnormality of eosinophils (HP:0001879) | 2.31043729 |
| 47 | Dyschromatopsia (HP:0007641) | 2.30833971 |
| 48 | Conical tooth (HP:0000698) | 2.30230992 |
| 49 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.24923430 |
| 50 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.24923430 |
| 51 | Abnormal protein glycosylation (HP:0012346) | 2.24923430 |
| 52 | Abnormal glycosylation (HP:0012345) | 2.24923430 |
| 53 | Pulmonary infiltrates (HP:0002113) | 2.23199471 |
| 54 | Recurrent cutaneous fungal infections (HP:0011370) | 2.22535383 |
| 55 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.22535383 |
| 56 | Abnormality of magnesium homeostasis (HP:0004921) | 2.18992500 |
| 57 | Recurrent fungal infections (HP:0002841) | 2.18847197 |
| 58 | Abnormality of B cell number (HP:0010975) | 2.18157626 |
| 59 | Muscle fiber atrophy (HP:0100295) | 2.15303179 |
| 60 | Increased IgM level (HP:0003496) | 2.11818879 |
| 61 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.11064614 |
| 62 | Severe visual impairment (HP:0001141) | 2.04902005 |
| 63 | Pancreatic cysts (HP:0001737) | 2.01722415 |
| 64 | Polyuria (HP:0000103) | 2.01590246 |
| 65 | Tetany (HP:0001281) | 1.98143537 |
| 66 | Keratoconjunctivitis sicca (HP:0001097) | 1.96218580 |
| 67 | Leukocytosis (HP:0001974) | 1.95950728 |
| 68 | Ketosis (HP:0001946) | 1.94231684 |
| 69 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.94144438 |
| 70 | Keratoconjunctivitis (HP:0001096) | 1.92117380 |
| 71 | Dicarboxylic aciduria (HP:0003215) | 1.91956193 |
| 72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.91956193 |
| 73 | Mediastinal lymphadenopathy (HP:0100721) | 1.90665088 |
| 74 | Eosinophilia (HP:0001880) | 1.89773567 |
| 75 | Hypoplasia of the uterus (HP:0000013) | 1.89608883 |
| 76 | Hyperammonemia (HP:0001987) | 1.86095956 |
| 77 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.85340273 |
| 78 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.84553138 |
| 79 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.84242001 |
| 80 | Short middle phalanx of the 5th finger (HP:0004220) | 1.84089831 |
| 81 | Meningitis (HP:0001287) | 1.83497051 |
| 82 | Mesomelia (HP:0003027) | 1.80286026 |
| 83 | Pancreatitis (HP:0001733) | 1.79514628 |
| 84 | Albinism (HP:0001022) | 1.77760198 |
| 85 | Broad-based gait (HP:0002136) | 1.77353455 |
| 86 | Cortical visual impairment (HP:0100704) | 1.76448667 |
| 87 | Hemoptysis (HP:0002105) | 1.75949967 |
| 88 | Type II lissencephaly (HP:0007260) | 1.73928569 |
| 89 | Neutropenia (HP:0001875) | 1.72960227 |
| 90 | Brushfield spots (HP:0001088) | 1.72936747 |
| 91 | Recurrent abscess formation (HP:0002722) | 1.71853098 |
| 92 | Abnormality of DNA repair (HP:0003254) | 1.71714272 |
| 93 | Decreased central vision (HP:0007663) | 1.70603944 |
| 94 | Opisthotonus (HP:0002179) | 1.69207113 |
| 95 | Large for gestational age (HP:0001520) | 1.68904714 |
| 96 | Chronic hepatic failure (HP:0100626) | 1.68738495 |
| 97 | Methylmalonic acidemia (HP:0002912) | 1.67943454 |
| 98 | Facial diplegia (HP:0001349) | 1.67266739 |
| 99 | Oral leukoplakia (HP:0002745) | 1.65300181 |
| 100 | Fair hair (HP:0002286) | 1.64842746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.05707444 |
| 2 | FES | 4.03040155 |
| 3 | ZAK | 3.15588912 |
| 4 | KIT | 2.94862100 |
| 5 | TESK2 | 2.78057089 |
| 6 | TLK1 | 2.70391050 |
| 7 | MUSK | 2.68877165 |
| 8 | KDR | 2.46178196 |
| 9 | ADRBK2 | 2.33899642 |
| 10 | PINK1 | 2.32099340 |
| 11 | MST4 | 2.11045512 |
| 12 | GRK1 | 2.03573724 |
| 13 | MAP2K2 | 2.02717261 |
| 14 | IKBKE | 1.99028284 |
| 15 | TAOK3 | 1.96655440 |
| 16 | MAP4K1 | 1.79219585 |
| 17 | IKBKB | 1.77683870 |
| 18 | NUAK1 | 1.75961335 |
| 19 | CSF1R | 1.71457204 |
| 20 | WNK4 | 1.68091337 |
| 21 | JAK3 | 1.63988730 |
| 22 | PHKG2 | 1.60862459 |
| 23 | PHKG1 | 1.60862459 |
| 24 | MAP3K14 | 1.56946767 |
| 25 | TBK1 | 1.54018422 |
| 26 | VRK2 | 1.53572259 |
| 27 | FRK | 1.50822444 |
| 28 | GRK6 | 1.48492730 |
| 29 | SIK3 | 1.45426307 |
| 30 | EIF2AK3 | 1.38000851 |
| 31 | JAK1 | 1.37128053 |
| 32 | FER | 1.36765897 |
| 33 | ITK | 1.35788192 |
| 34 | CSK | 1.35528065 |
| 35 | TYK2 | 1.28281310 |
| 36 | MAPK11 | 1.16154836 |
| 37 | MARK3 | 1.10059200 |
| 38 | BRSK2 | 1.10015793 |
| 39 | SYK | 1.05811696 |
| 40 | HCK | 1.04622296 |
| 41 | TEC | 1.03543629 |
| 42 | LCK | 0.99826575 |
| 43 | LYN | 0.98782912 |
| 44 | CDK8 | 0.97147149 |
| 45 | OXSR1 | 0.96386849 |
| 46 | MAPKAPK3 | 0.92010646 |
| 47 | PRKCQ | 0.89327223 |
| 48 | MATK | 0.89296803 |
| 49 | EIF2AK2 | 0.89047107 |
| 50 | BMPR1B | 0.87146187 |
| 51 | CDC7 | 0.84027065 |
| 52 | SCYL2 | 0.81957958 |
| 53 | NLK | 0.77388348 |
| 54 | TIE1 | 0.76907576 |
| 55 | IGF1R | 0.76597573 |
| 56 | ADRBK1 | 0.75722356 |
| 57 | MAP4K2 | 0.73013488 |
| 58 | PIM1 | 0.71810671 |
| 59 | TESK1 | 0.70712754 |
| 60 | PIK3CA | 0.69494872 |
| 61 | ZAP70 | 0.68793119 |
| 62 | MYLK | 0.67932349 |
| 63 | STK39 | 0.65972264 |
| 64 | RPS6KA5 | 0.64564776 |
| 65 | DAPK1 | 0.64537027 |
| 66 | SIK2 | 0.64322984 |
| 67 | LRRK2 | 0.63716378 |
| 68 | PDK2 | 0.62262673 |
| 69 | GRK5 | 0.62111361 |
| 70 | LIMK1 | 0.60754749 |
| 71 | BCKDK | 0.58967777 |
| 72 | PLK4 | 0.57511876 |
| 73 | STK10 | 0.51371213 |
| 74 | IRAK4 | 0.51014139 |
| 75 | TNK2 | 0.50944828 |
| 76 | MAP3K11 | 0.50429974 |
| 77 | ATR | 0.49981201 |
| 78 | TYRO3 | 0.49651640 |
| 79 | INSRR | 0.49211378 |
| 80 | PLK2 | 0.49199662 |
| 81 | EIF2AK1 | 0.44338027 |
| 82 | ABL1 | 0.42623610 |
| 83 | CAMKK1 | 0.41740739 |
| 84 | BTK | 0.39856338 |
| 85 | CAMKK2 | 0.38729681 |
| 86 | MAPKAPK5 | 0.38708294 |
| 87 | VRK1 | 0.38232030 |
| 88 | MAPK4 | 0.37793821 |
| 89 | INSR | 0.36967773 |
| 90 | PRKCI | 0.36827135 |
| 91 | EGFR | 0.36419710 |
| 92 | WNK3 | 0.36353799 |
| 93 | EPHB2 | 0.35307925 |
| 94 | MAP2K6 | 0.33689292 |
| 95 | MAPKAPK2 | 0.33039491 |
| 96 | MAPK7 | 0.32846514 |
| 97 | CHEK2 | 0.31466600 |
| 98 | CLK1 | 0.30513081 |
| 99 | BMPR2 | 0.29309743 |
| 100 | SRPK1 | 0.29236639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.75240372 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.48680861 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.39991872 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.36464316 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.34455354 |
| 6 | Asthma_Homo sapiens_hsa05310 | 3.00187754 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.85174171 |
| 8 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.74799618 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.73812794 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.60814250 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.38256709 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.32050866 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.13620010 |
| 14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.09259549 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.77788988 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.74840583 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.73090209 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.65765402 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.64975082 |
| 20 | RNA degradation_Homo sapiens_hsa03018 | 1.62632820 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.51216019 |
| 22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.47902393 |
| 23 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.37352491 |
| 24 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33466912 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.27780167 |
| 26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26405715 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.25771750 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.24523094 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24519756 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22546726 |
| 31 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.20352624 |
| 32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.19413989 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.14321683 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12084514 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.09283036 |
| 36 | Parkinsons disease_Homo sapiens_hsa05012 | 1.08925441 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08355117 |
| 38 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.05992481 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04273568 |
| 40 | Basal transcription factors_Homo sapiens_hsa03022 | 1.03912450 |
| 41 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.02470563 |
| 42 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.01810831 |
| 43 | Measles_Homo sapiens_hsa05162 | 1.01033414 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00094509 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.00005976 |
| 46 | Leishmaniasis_Homo sapiens_hsa05140 | 0.96806256 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94451815 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90459710 |
| 49 | Ribosome_Homo sapiens_hsa03010 | 0.88687671 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.88321794 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82500765 |
| 52 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81979721 |
| 53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81063197 |
| 54 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78236594 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.78103521 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 0.77718981 |
| 57 | Protein export_Homo sapiens_hsa03060 | 0.77452205 |
| 58 | Phototransduction_Homo sapiens_hsa04744 | 0.74958044 |
| 59 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73813575 |
| 60 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.69585414 |
| 61 | Base excision repair_Homo sapiens_hsa03410 | 0.68138448 |
| 62 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68135089 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.67023538 |
| 64 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.66382689 |
| 65 | Purine metabolism_Homo sapiens_hsa00230 | 0.66340710 |
| 66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.62475405 |
| 67 | Olfactory transduction_Homo sapiens_hsa04740 | 0.61798709 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 0.60088236 |
| 69 | Homologous recombination_Homo sapiens_hsa03440 | 0.59016055 |
| 70 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57552151 |
| 71 | Alzheimers disease_Homo sapiens_hsa05010 | 0.55704240 |
| 72 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.55156944 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53614749 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49770313 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46486148 |
| 76 | Malaria_Homo sapiens_hsa05144 | 0.46415277 |
| 77 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43458098 |
| 78 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42259709 |
| 79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.40768822 |
| 80 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40517964 |
| 81 | Apoptosis_Homo sapiens_hsa04210 | 0.39028544 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37940582 |
| 83 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.37359370 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.36639789 |
| 85 | Tuberculosis_Homo sapiens_hsa05152 | 0.35732999 |
| 86 | Morphine addiction_Homo sapiens_hsa05032 | 0.33766763 |
| 87 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.33285555 |
| 88 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32781678 |
| 89 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.31057097 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30915941 |
| 91 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.26466940 |
| 92 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.24541841 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23771309 |
| 94 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.23513604 |
| 95 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.23458344 |
| 96 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.23113831 |
| 97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.21665220 |
| 98 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.17780175 |
| 99 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.17753578 |
| 100 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.15584360 |

